Follow the Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Market capitalisation: €13.4bn. The latest transaction was filed on 3 July 2026 (Sale). Among the most active insiders: LIU Gexin. All data is accessible without an account.
35
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€106m
34 ops.
Sell Volume
20Σ signal
Buys n/a€106m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,409 of 26,550 companies
51.6
score / 100
Value
33
Quality
71
FCF yld-6.5%
Earn yld3.0%
EV/EBITDA18.4x
ROE7.3%
Gross mgn80%
Net mgn13%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
75,400 shares@ €45.95696.6% of flowShareXHKGHKEX:DA20260618E00187
25 of 35 declarations
About Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based biopharmaceutical company focused on the development and manufacturing of innovative drugs. It is listed on the H-share market.